Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sanara MedTech (SMTI) Cash from Operations (2016 - 2025)

Sanara MedTech (SMTI) has disclosed Cash from Operations for 15 consecutive years, with 2176441.0 as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Cash from Operations rose 6.14% year-over-year to 2176441.0, compared with a TTM value of 3773615.0 through Sep 2025, up 309.14%, and an annual FY2024 reading of 23784.0, up 99.27% over the prior year.
  • Cash from Operations was 2176441.0 for Q3 2025 at Sanara MedTech, down from 2664011.0 in the prior quarter.
  • Across five years, Cash from Operations topped out at 2664011.0 in Q2 2025 and bottomed at 2112478.0 in Q1 2022.
  • Average Cash from Operations over 5 years is 568272.0, with a median of 1261604.0 recorded in 2021.
  • The sharpest move saw Cash from Operations tumbled 245.3% in 2022, then skyrocketed 288.68% in 2025.
  • Year by year, Cash from Operations stood at 1784358.0 in 2021, then surged by 63.85% to 645016.0 in 2022, then crashed by 31.55% to 848532.0 in 2023, then skyrocketed by 209.84% to 932047.0 in 2024, then surged by 133.51% to 2176441.0 in 2025.
  • Business Quant data shows Cash from Operations for SMTI at 2176441.0 in Q3 2025, 2664011.0 in Q2 2025, and 1998884.0 in Q1 2025.